Clinical Pathology Articles & Analysis
11 news found
During her time at the Charité Universitätsmedizin Berlin in Germany, Blum, MD, PhD played a central role in developing a GMP-compliant clinical platform for the use of TCR based cellular therapy in refractory AML, high-risk multiple myeloma and metastatic melanoma. In the context of complex government-sponsored initiatives she was able to coordinate activities of ...
ByArdigen
In this new role, Dr. Chadha will lead all clinical and medical affairs as the company continues to develop, validate, and commercialize its AI-driven digital biomarker platform. ...
Publication of a large new study2 in the Journal of Clinical Pathology comparing the difference in turnaround time between in-house automated rapid PCR3 -based EGFR analysis and Next-Generation Sequencing (NGS) by an external laboratory, showing that 6% of the patients died before the NGS report was available. ...
MyOptiLab carries out complete analyses designed specifically for clinical pathology labs. It uses the Lean and Six Sigma methodologies applied widely in the industry and provides solutions for increasing productivity and improving patient quality of service. ...
“This publication shows for the first time that WATS3D helps to detect clinically-significant pathologic lesions and provides insight into the progression rates of BE and dysplasia to cancer,” said Bill Huffnagle, CEO of CDx Diagnostics. ...
Based on user analysis and evaluation of feedback from clinics, therapists and patients, we have further developed our system to relieve therapists. ...
Since lipidomics profiles are of great importance for studying developmental or pathological processes in tissue sections, MALDI-Imaging can serve as a useful tool for biomarker discovery. ...
This study highlighted the utility of the PARIS® Test, a CLIA certified functional drug sensitivity assay, to support clinical decision making in heterogeneous disease such as breast cancer. Authors found that the PARIS® Test: Showed a high success rate (70.5%) in delivering a report ranking targeted, endocrine and chemotherapy agents in a clinically ...
Data obtained in real-life setting from more than 800 patients with node-negative or nodepositive early-stage breast cancer highlight the test’s impact on clinical practice with chemotherapy-sparing effect Publication of landmark TAILORx study results led to greater reduction in chemotherapy recommendations Exact Sciences Corp. today announced results from a ...
McGuire Memorial Lecture Award at 2019 San Antonio Breast Cancer Symposium New Publication of Long-term Data from Real-world Clinical Practice Confirms Conclusions of TAILORx Exact Sciences Corp. ...
A comprehensive exam that includes an ultra-widefield optomap® image has been shown in clinical studies to enhance pathology detection and disease management, as well as to improve clinic flow. ...